C07D 493/10
Spiro-condensed systems
C07D493/10 (Spiro-condensed systems) appears on 1,193 US grants and 919 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,193
- Published applications
- 919
- Assignees
- 590
- Inventors
- 3,191
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 17 | 0 |
| 1977 | 12 | 0 |
| 1978 | 21 | 0 |
| 1979 | 15 | 0 |
| 1980 | 19 | 0 |
| 1981 | 16 | 0 |
| 1982 | 20 | 0 |
| 1983 | 13 | 0 |
| 1984 | 18 | 0 |
| 1985 | 23 | 0 |
| 1986 | 19 | 0 |
| 1987 | 21 | 0 |
| 1988 | 11 | 0 |
| 1989 | 25 | 0 |
| 1990 | 18 | 0 |
| 1991 | 17 | 0 |
| 1992 | 23 | 0 |
| 1993 | 20 | 0 |
| 1994 | 22 | 0 |
| 1995 | 16 | 0 |
| 1996 | 8 | 0 |
| 1997 | 33 | 0 |
| 1998 | 23 | 0 |
| 1999 | 25 | 0 |
| 2000 | 24 | 0 |
| 2001 | 24 | 1 |
| 2002 | 30 | 23 |
| 2003 | 19 | 23 |
| 2004 | 23 | 27 |
| 2005 | 7 | 33 |
| 2006 | 9 | 35 |
| 2007 | 18 | 25 |
| 2008 | 17 | 39 |
| 2009 | 26 | 30 |
| 2010 | 28 | 45 |
| 2011 | 27 | 45 |
| 2012 | 31 | 47 |
| 2013 | 35 | 32 |
| 2014 | 33 | 46 |
| 2015 | 36 | 49 |
| 2016 | 50 | 45 |
| 2017 | 42 | 50 |
| 2018 | 41 | 46 |
| 2019 | 31 | 50 |
| 2020 | 41 | 36 |
| 2021 | 24 | 32 |
| 2022 | 32 | 34 |
| 2023 | 24 | 50 |
| 2024 | 19 | 30 |
| 2025 | 30 | 30 |
| 2026 | 17 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Fibroblast activation protein ligands for targeted delivery applications29 Sep 2026US 12,747,224 B2Philochem AG
- Fluorescent ion indicators and their applications29 Sep 2026US 12,748,118 B2AAT Bioquest, Inc.
- Compounds constituting C20-modified salinomycin derivatives, a method for obtaining the same, a composition containing the same, a use of said compounds and a method for obtaining an intermediate product22 Sep 2026US 12,741,974 B2Fileclo Sp. Z O.O.
- Solid supports and phosphoramidite building blocks for oligonucleotide conjugates15 Sep 2026US 12,735,387 B2AM Chemicals LLC
- N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides8 Sep 2026US 12,729,196 B2AstraZeneca AB
- Compounds for treating cancer1 Oct 2026US 2026/0297066 A1Genesis Molecular AI, Inc.
- JAK2 Inhibitors And Their Use As Pharmaceuticals3 Sep 2026US 2026/0258014 A1
- Bi-specific adapters and their use with universal car-t cells in the treatment of tumors and the inhibition of cancer-associated fibroblasts27 Aug 2026US 2026/0248923 A1Purdue Research Foundation
- Therapeutic alkaloid compounds13 Aug 2026US 2026/0234131 A1Sensorium Therapeutics, Inc.
- Erap1 modulating compounds16 Jul 2026US 2026/0199455 A1Grey Wolf Therapeutics Limited
Most cited
By later US patents
- Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers186US 4,318,846 ASyva Company · 1982
- Apparatus and method for a custom soft-solid hearing aid155US 6,473,512 B1Softear Technologies, L.L.C. · 2002
- Xanthene dyes having a fused (C) benzo ring128US 4,945,171 AMolecular Probes, Inc. · 1990
- 5(6)-Methyl substituted fluorescein derivatives121US 5,573,904 AAbbott Laboratories · 1996
- 5(6)-methyl substituted fluorescein derivatives118US 5,352,803 AAbbott Laboratories · 1994